113 related articles for article (PubMed ID: 35679052)
1. The impact of a 24-hour syringe dispensing machine on a face-to-face needle and syringe program and targeted primary healthcare clinic.
Uthurralt N; McGlinn A; O'Donnell M; Haber PS; Day CA
Aust N Z J Public Health; 2022 Aug; 46(4):524-526. PubMed ID: 35679052
[TBL] [Abstract][Full Text] [Related]
2. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia.
White B; Haber PS; Day CA
Int J Drug Policy; 2016 Jan; 27():121-6. PubMed ID: 26118798
[TBL] [Abstract][Full Text] [Related]
3. The impact of an automatic syringe dispensing machine in inner-city Sydney, Australia: No evidence of a 'honey-pot' effect.
Day CA; White B; Haber PS
Drug Alcohol Rev; 2016 Sep; 35(5):637-43. PubMed ID: 27073122
[TBL] [Abstract][Full Text] [Related]
4. Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study.
Coupland H; Henderson C; Pritchard-Jones J; Kao SC; Sheils S; Nagy R; O'Donnell M; Haber PS; Day CA
Harm Reduct J; 2022 May; 19(1):56. PubMed ID: 35643528
[TBL] [Abstract][Full Text] [Related]
5. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
[TBL] [Abstract][Full Text] [Related]
6. "No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
Walker S; Curtis M; Kirwan A; Thatcher R; Dietze P
Harm Reduct J; 2024 Feb; 21(1):51. PubMed ID: 38402389
[TBL] [Abstract][Full Text] [Related]
7. Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia.
O'Keefe D; Livingston M; Cossar RD; Kerr P; Jacka D; Dietze P
Harm Reduct J; 2022 Sep; 19(1):101. PubMed ID: 36071500
[TBL] [Abstract][Full Text] [Related]
8. Analysis of four syringe dispensing machine point-of-access data 2017-2020 in Melbourne, Australia: machine utilisation and client demographics.
Kerr P; Cossar RD; Livingston M; Jacka D; Dietze P; O'Keefe D
Harm Reduct J; 2022 Dec; 19(1):144. PubMed ID: 36544124
[TBL] [Abstract][Full Text] [Related]
9. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
[TBL] [Abstract][Full Text] [Related]
10. Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.
McCormack AR; Aitken CK; Burns LA; Cogger S; Dietze PM
Am J Epidemiol; 2016 May; 183(9):852-60. PubMed ID: 27049004
[TBL] [Abstract][Full Text] [Related]
11. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
12. Staff perceptions of syringe dispensing machines in Australia: a pilot study.
Islam MM; Conigrave KM; Stern T
Subst Use Misuse; 2009; 44(4):490-501. PubMed ID: 19283622
[TBL] [Abstract][Full Text] [Related]
13. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
14. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
15. Co-design of harm reduction materials for people who inject drugs to implement research findings.
Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM
Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536
[TBL] [Abstract][Full Text] [Related]
16. Long-term survey of a syringe-dispensing machine needle exchange program: answering public concerns.
Duplessy C; Reynaud EG
Harm Reduct J; 2014 May; 11():16. PubMed ID: 24885902
[TBL] [Abstract][Full Text] [Related]
17. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.
Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Farhoudian A; Ghiasvand H; Vameghi M; Rezaei O; Sayadnasiri M; Pouya RH
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S303-S308. PubMed ID: 29271013
[TBL] [Abstract][Full Text] [Related]
18. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
[TBL] [Abstract][Full Text] [Related]
19. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
O'Keefe D; Scott N; Aitken C; Dietze P
Drug Alcohol Depend; 2017 Jul; 176():7-13. PubMed ID: 28463684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
